You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastrointestinal Neuroendocrine Carcinomas

Showing 1 - 25 of 6,166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) Trial in San Francisco, Boston, New York (Pembrolizumab, Irinotecan,

Completed
Has Results
  • High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
  • San Francisco, California
  • +2 more
Dec 5, 2022

Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

Recruiting
  • Neuroendocrine Tumours (NET)
  • Neuroendocrine Carcinomas (NEC)
  • Santiago De Compostela, Galicia, Spain
  • +4 more
Aug 1, 2022

Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

Recruiting
  • Gastrointestinal Neuroendocrine Carcinoma
  • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 1, 2023

Carcinomas, Cervix Cancer, Cervical Cancer Trial in Houston (AK104)

Recruiting
  • Carcinomas
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Epiction of Genomic and Genetic Landscape Identifies CCL5

Completed
  • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
    • (no location specified)
    Jan 27, 2023

    Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • +6 more
    • (no location specified)
    Aug 4, 2023

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • (no location specified)
    Oct 16, 2023

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
    • long-acting Octreotide.
    • (no location specified)
    May 22, 2023

    Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

    Recruiting
    • Small Cell Lung Cancer
    • Neuroendocrine Carcinoma
    • Chiba, Japan
    • +1 more
    Jan 16, 2023

    Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

    Not yet recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Gastroenteropancreatic Neuroendocrine Neoplasm
    • TQ Formula (black seed oil capsules)
    • +2 more
    • Cleveland, Ohio
      University hospitals Seidman Cancer Center, Case Comprehensive C
    Aug 12, 2022

    GastroIntestinal Cancer in Children and Adolescents

    Active, not recruiting
    • Gastrointestinal Cancer
    • +6 more
      • Leiden, South-Holland, Netherlands
      • +1 more
      Jan 11, 2023

      Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

      Not yet recruiting
      • Neuroendocrine Neoplasms
      • BI 764532
      • +3 more
      • (no location specified)
      Nov 10, 2023

      Pancreatic Neuroendocrine Tumors and Carcinomas

      Recruiting
      • Cancer of Pancreas
        • Strasbourg, France
          Service d'Oncologie - CHU de Strasbourg - France
        Jan 31, 2022

        Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

        Not yet recruiting
        • Small-cell Lung Cancer
        • Neuroendocrine Carcinoma
        • (no location specified)
        Jun 13, 2022

        Cancer Trial in Germany (Avelumab)

        Completed
        • Cancer
        • Halle (Saale), Germany
        • +3 more
        Feb 24, 2022

        Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

        Active, not recruiting
        Has Results
        • Neuroendocrine Tumors
        • Carcinoid Tumors
        • Pasireotide Long Acting Release (LAR)
        • Stanford, California
        • +1 more
        Jan 11, 2022

        Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

        Not yet recruiting
        • Small Cell Lung Carcinoma
        • Neuroendocrine Neoplasms
        • BI 764532
        • (no location specified)
        May 22, 2023

        Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

        Terminated
        • Neuroendocrine Tumors
        • +2 more
        • Denver, Colorado
        • +2 more
        Jul 5, 2022

        Cancer of Stomach, Oesophageal Cancer, Gastric Cancer Trial in Sydney

        Recruiting
        • Cancer of Stomach
        • +8 more
          • Sydney, New South Wales, Australia
            Westmead Hospital
          Mar 26, 2023

          Advanced or Metastatic EP-NEC Trial in Wuhan (Camrelizumab, Etoposide, Carboplatin)

          Not yet recruiting
          • Advanced or Metastatic EP-NEC
          • Wuhan, Hubei, China
            Tongji Hospital，Tongji Medical College Affiliated，Huazhong Unive
          Nov 22, 2021

          Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

          Not yet recruiting
          • Neuroendocrine Tumors
          • +8 more
          • Iowa City, Iowa
          • +1 more
          Nov 23, 2022

          Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

          Not yet recruiting
          • Neuroendocrine Tumor (NET)
          • Colorectal Cancer (CRC)
          • CHM-2101 CAR-T cells
          • (no location specified)
          Sep 20, 2023

          Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate

          Completed
          • Gastrointestinal Stromal Tumors
          • +2 more
          • Sunitinib malate capsules generic product
          • Sunitinib malate capsules reference product
          • Changchun, Jilin, China
            Affiliated Hospital of Changchun University of Traditional Chine
          Apr 6, 2023